ResMed Inc. vs YieldMax TSLA Option Income Strategy ETF — how do they compare? ResMed Inc. trades at $220 (market cap $32.61B), while YieldMax TSLA Option Income Strategy ETF trades at $21.93. The key difference: ResMed Inc. pays a 1.17% dividend while YieldMax TSLA Option Income Strategy ETF pays none, and ResMed Inc. is trading nearer its 52-week high, YieldMax TSLA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| RMD | TSLY | |
|---|---|---|
Market Cap | $32.61B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $293.73 | $48.25 |
52-Week Low | $182.82 | $20.49 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.17% | — |
Trailing returns across standard periods
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →